XML 40 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Share-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Restricted Stock Activity
Restricted stock activity for the year ended December 31, 2022 and the three months ended March 31, 2023 was as follows:
RSAWeighted Average Grant PricePRSUWeighted Average Grant PriceRSUWeighted Average Grant PriceTotalWeighted Average Grant Price
Nonvested balance as of December 31, 2021141,617 $23.06 63,120 $28.20 5,052 $23.56 209,789 $24.62 
Granted (1)
62,560 34.04 37,335 24.71 3,115 27.95 103,010 30.47 
Vested(62,353)23.21 (43,020)18.91 (2,062)23.20 (107,435)21.49 
Forfeited(8,507)26.15 — — — — (8,507)26.15 
Nonvested balance as of December 31, 2022133,317 27.95 57,435 32.89 6,105 25.92 196,857 29.32 
Granted (1)
— — 16,780 40.61 43,160 36.42 59,940 37.59 
Vested(44,307)26.02 — — (3,048)25.37 (47,355)25.98 
Forfeited(1,923)26.73 — — — — (1,923)26.73 
Nonvested balance as of March 31, 202387,087 $28.95 74,215 $34.63 46,217 $35.76 207,519 $32.50 
Unrecognized compensation cost (in thousands)$2,111 $1,513 $1,595 $5,219 
Weighted average remaining recognition period (in years)2.322.143.532.64
(1)The number of restricted shares/units shown includes the shares that would be granted if the target level of performance is achieved related to the performance based restricted stock units. The number of shares actually issued may vary.
Share-based Payment Arrangement, Expensed and Capitalized, Amount
Share-based compensation expense related to restricted stock and ESPP included in the unaudited Consolidated Statements of Income was as follows:
For the Three Months Ended March 31,
20232022
(In Thousands)
Share-based compensation expense$634 $609